Name:
Professor Mike Rieder
Organisation:
University of Western Ontario
Year elected:
2021
Primary professional setting:
Dr Rieder obtained his MD at the University of Saskatchewan in 1980 and his PhD at the University of Toronto in 1992. His paediatric training was at Children's Hospital of Michigan and he completed fellowships in Paediatric Clinical Pharmacology and Paediatric Emergency Medicine at the Hospital for Sick Children in Toronto. Dr. Rieder is a Professor with the Department of Paediatrics, Physiology and Pharmacology and Medicine at Western University and a Scientist at Robarts Research Institute. He is Past President of the Canadian Society of Pharmacology and Therapeutics, is a member of the Drug Therapy Committee, Canadian Paediatric Society, and has served as a consultant to Health Canada, the NIH and the MRC. Dr. Rieder's research focuses on drug safety, adverse drug reactions and optimal therapeutics in children including studying genetic variations on drug efficacy and safety. Dr. Rieder also studies drug policy in children and the impact of changes in drug regulation on children’s care. He has received many national and international awards and holds the CIHR-GSK Chair in Paediatric Clinical Pharmacology, the only endowed Chair in Paediatric Clinical Pharmacology in Canada.